Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PedMAb1
PACTR202205715278722Phase 1Unknown
- Sponsor
- South African Medical Research Council
- Start
- Jun 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of CAP256V2LS and VRC07-523LS in human immunodeficiency virus infection (HIV) (4 arms), sponsored by South African Medical Research Council. Status: unknown.
02
Drugs
CAP256V2LSVRC07-523LS
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202205715278722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202205715278722.